ACTIVE

B&B PHARMA

Financial year 2024 · closed on 31/12/2024
Net result
30,2 k €
-91.2% YoY
Gross margin
138,4 k €
-62.0% YoY
Equity
212,2 k €
-44.4% YoY

What does B&B PHARMA do?

B&B PHARMA is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beersel.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0554.988.666
Incorporation
02/07/2014
Legal form
Private limited company
Registered office
Blarenveld 18
1650 Beersel · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Signals
ProfitablePositive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2024202320222021202020192018201720162015
Income statement
Gross margin138,4 k €364,2 k €236,6 k €164,4 k €94,9 k €85,4 k €3,4 k €115,1 k €68,3 k €111,2 k €
EBITDA138,2 k €363,3 k €236,5 k €162,7 k €94,6 k €85,4 k €3,4 k €113,7 k €68,3 k €108,5 k €
Operating result123,4 k €348,2 k €220,9 k €147,7 k €80,8 k €72 k €-38,8 k €111,4 k €66,4 k €108,2 k €
Net result30,2 k €341,5 k €169,4 k €225,7 k €127,2 k €50,9 k €-61,6 k €61,8 k €29,3 k €56,3 k €
Balance sheet
Equity212,2 k €382 k €40,5 k €149,1 k €148,9 k €139,3 k €91,9 k €153,6 k €91,8 k €62,5 k €
Total assets860,9 k €901,9 k €864,1 k €881,6 k €890,4 k €966,4 k €910,3 k €760,6 k €807,1 k €779 k €
Cash10,3 k €7 k €15,1 k €23,1 k €1,4 k €1,2 k €9,3 k €912,1 €48,2 k €18,9 k €
Debts641,2 k €519,9 k €823,5 k €732,4 k €741,5 k €827,2 k €818,4 k €607,1 k €715,3 k €716,4 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 3 ended

Active mandates

Balthazar Emmanuel

Director · since 02 juillet 2014

Active
Nassima Boulal

Director · since 02 juillet 2014

Active

Ended mandates

Emmanuel BALTHAZAR

Manager · since 02 juillet 2014

Ended
NASSIMA BOULAL

Manager · since 02 juillet 2014

Ended
Emmanuel BALTHAZAR

Manager

Ended
Annual accounts

Full financial information

202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date19/08/202529/08/202406/08/202313/07/202202/07/202107/07/2020
General meeting23/07/202531/07/202430/06/202308/06/202209/06/202110/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202423/07/202519/08/2025FrenchPDF
Abridged model31/12/202331/07/202429/08/2024FrenchPDF
Abridged model31/12/202230/06/202306/08/2023DutchPDF
Abridged model31/12/202108/06/202213/07/2022DutchPDF
Abridged model31/12/202009/06/202102/07/2021FrenchPDF
Micro model31/12/201910/06/202007/07/2020FrenchPDF
Abridged model31/12/201812/06/201928/08/2019FrenchPDF
Abridged model31/12/201713/06/201831/07/2018FrenchPDF
Abridged model31/12/201614/06/201730/08/2017FrenchPDF
Abridged modelCorrection31/12/201522/09/201623/09/2016FrenchPDF
Abridged model31/12/201512/05/201613/05/2016FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 3 ended

Active mandates

Balthazar Emmanuel

Director · since 02 juillet 2014

Active
Nassima Boulal

Director · since 02 juillet 2014

Active

Ended mandates

Emmanuel BALTHAZAR

Manager · since 02 juillet 2014

Ended
NASSIMA BOULAL

Manager · since 02 juillet 2014

Ended
Emmanuel BALTHAZAR

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other11/12/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates23/04/2024
    ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Registered office14/05/2018
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Registered office03/03/2016
    SIEGE SOCIAL
    PDF
  • Mandates03/03/2015
    DEMISSIONS, NOMINATIONS
    PDF
  • Other04/07/2014
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202430,2 k €
  2. 2023
    Annual accounts 2023341,5 k €
  3. 2023
    Name changeBB PHARMA
  4. 2022
    Annual accounts 2022169,4 k €
  5. 2021
    Annual accounts 2021225,7 k €
  6. 2021
    Name changeB&B PHARMA
  7. 2020
    Annual accounts 2020127,2 k €
  8. 2019
    Annual accounts 201950,9 k €
  9. 2018
    Annual accounts 2018-61,6 k €
  10. 2017
    Annual accounts 201761,8 k €
  11. 2016
    Annual accounts 201629,3 k €
  12. 2015
    Annual accounts 201556,3 k €
  13. 02/07/2014
    IncorporationPrivate limited company